SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 152 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,000 | -26.7% | 2,550 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $15,000 | +66.7% | 2,550 | +104.0% | 0.00% | +50.0% |
| Q4 2021 | $9,000 | -90.6% | 1,250 | -87.6% | 0.00% | -96.4% |
| Q1 2019 | $96,000 | -52.0% | 10,050 | -42.2% | 0.06% | -57.3% |
| Q4 2018 | $200,000 | +1.5% | 17,400 | +49.4% | 0.13% | +28.4% |
| Q3 2018 | $197,000 | +95.0% | 11,650 | +1.3% | 0.10% | +61.9% |
| Q2 2017 | $101,000 | -39.5% | 11,500 | -64.3% | 0.06% | -39.4% |
| Q1 2017 | $167,000 | +11.3% | 32,200 | -34.6% | 0.10% | +10.6% |
| Q4 2016 | $150,000 | -28.9% | 49,200 | +8.1% | 0.09% | -30.4% |
| Q3 2016 | $211,000 | -25.7% | 45,500 | -7.1% | 0.14% | -26.6% |
| Q2 2016 | $284,000 | +8.0% | 49,000 | +12.6% | 0.18% | +4.5% |
| Q1 2016 | $263,000 | +64.4% | 43,500 | +148.6% | 0.18% | +70.9% |
| Q4 2015 | $160,000 | – | 17,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,032,980 | $12,950,000 | 1.82% |
| EcoR1 Capital, LLC | 2,308,079 | $14,702,000 | 1.54% |
| Alexandria Capital, LLC | 1,005,119 | $6,403,000 | 1.05% |
| Casdin Capital, LLC | 1,455,000 | $9,268,000 | 0.98% |
| Rhenman & Partners Asset Management AB | 700,000 | $4,459,000 | 0.62% |
| Bellevue Group AG | 3,850,000 | $24,525,000 | 0.48% |
| GREAT POINT PARTNERS LLC | 633,505 | $4,035,000 | 0.42% |
| WASATCH ADVISORS LP | 5,938,434 | $37,828,000 | 0.39% |
| 361 CAPITAL LLC | 109,161 | $695,000 | 0.32% |
| Ceeto Capital Group, LLC | 50,000 | $319,000 | 0.26% |